QSIAW vs. RXRX
QSIAW (Quantum-Si incorporated) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, QSIAW returned -69.69%/yr vs -37.56%/yr for RXRX. At a 0.14 correlation, their price movements are largely independent.
Performance
QSIAW vs. RXRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QSIAW achieves a -96.61% return, which is significantly lower than RXRX's -22.25% return.
QSIAW
- 1D
- 0.00%
- 1M
- -81.06%
- YTD
- -96.61%
- 6M
- -97.57%
- 1Y
- -98.92%
- 3Y*
- -69.91%
- 5Y*
- -69.69%
- 10Y*
- —
RXRX
- 1D
- -1.55%
- 1M
- 5.65%
- YTD
- -22.25%
- 6M
- -27.73%
- 1Y
- -36.78%
- 3Y*
- -24.40%
- 5Y*
- -37.56%
- 10Y*
- —
QSIAW vs. RXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
QSIAW Quantum-Si incorporated | -96.61% | -83.96% | 295.68% | 26.37% | -86.10% | -52.04% |
RXRX Recursion Pharmaceuticals, Inc. | -22.25% | -39.50% | -31.44% | 27.89% | -54.99% | -43.33% |
Correlation
The correlation between QSIAW and RXRX is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021 | 0.14 |
Fundamentals
QSIAW:
$1.47M
RXRX:
$1.68B
QSIAW:
-$0.51
RXRX:
-$1.17
QSIAW:
0.74
RXRX:
23.03
QSIAW:
0.01
RXRX:
1.64
QSIAW:
$1.85M
RXRX:
$66.29M
QSIAW:
-$3.71M
RXRX:
-$22.83M
QSIAW:
-$104.05M
RXRX:
-$505.90M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QSIAW vs. RXRX — Risk / Return Rank
QSIAW
RXRX
QSIAW vs. RXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quantum-Si incorporated (QSIAW) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QSIAW | RXRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.03 | ||
| Sortino ratioReturn per unit of downside risk | -1.24 | ||
| Omega ratioGain probability vs. loss probability | 0.80 | 0.95 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | -0.63 | -0.37 |
| Martin ratioReturn relative to average drawdown | -1.45 | -1.00 | -0.46 |
Loading charts...
Drawdowns
QSIAW vs. RXRX - Drawdown Comparison
The maximum QSIAW drawdown since its inception was -99.83%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for QSIAW and RXRX.
Loading charts...
Drawdown Indicators
| QSIAW | RXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.83% | -93.13% | -6.70% |
Max Drawdown (1Y)Largest decline over 1 year | -99.15% | -58.17% | -40.98% |
Max Drawdown (3Y)Largest decline over 3 years | -99.68% | -82.09% | -17.59% |
Max Drawdown (5Y)Largest decline over 5 years | -99.83% | -93.13% | -6.70% |
Current DrawdownCurrent decline from peak | -99.83% | -92.31% | -7.52% |
Average DrawdownAverage peak-to-trough decline | -85.01% | -75.44% | -9.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 68.51% | 36.93% | +31.58% |
Volatility
QSIAW vs. RXRX - Volatility Comparison
Quantum-Si incorporated (QSIAW) has a higher volatility of 98.59% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 25.24%. This indicates that QSIAW's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QSIAW | RXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 98.59% | 25.24% | +73.35% |
Volatility (6M)Calculated over the trailing 6-month period | 161.68% | 45.47% | +116.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 204.59% | 71.27% | +133.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 213.32% | 93.66% | +119.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 213.64% | 93.53% | +120.11% |
Dividends
QSIAW vs. RXRX - Dividend Comparison
Neither QSIAW nor RXRX has paid dividends to shareholders.
Financials
QSIAW vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Quantum-Si incorporated and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
QSIAW and RXRX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QSIAW has higher volatility (98.59%) compared to RXRX (25.24%). In terms of maximum drawdown, QSIAW dropped -99.83% vs RXRX's -93.13%.
QSIAW currently has the higher Sharpe Ratio (-0.48 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QSIAW and RXRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer